1Park JW,Suh GI,Shin HE.Association between cerebrospinal fluid S100B protein and neuronal damage in patients with central nervous system infections[J].Yonsei Med J,2013,54(3):567-571.
3Kleindienst A,Hesse F,Bullock MR,et al.The neurotrophic protein S100B:value as a marker of brain damage and possible therapeutic implications[J].Prog Brain Res,2007,161(6):317-325.
4Gazzolo D,Grutzfeld D,Michetti F,et al.Increased S100B in cerebrospinal fluid of infants with bacterial meningitis:relationship to brain damage and routine cerebrospinal fluid findings[J].Clin Chem,2004,50(5):941-944.
5Jung K,Goerdt C,Lange P,et al.The use of S100B and Tau protein concentrations in the cerebrospinal fluid for the differential diagnosis of bacterial meningitis:a retrospective analysis[J].Eur Neurol,2011,66(3):128-132.
6Xia W,Han J,Huang G,et al.Inflammation in ischaemic brain injury:current advances and future perspectives[J].Clin Exp Pharmacol Physiol,2010,37(2):253-258.
7Abraha HD,Butterworth RJ,Bath PM,et al.Serum S-100 protein,relationship to clinical outcome in acute stroke[J].Clin Biochem,1997,34(5):5546-5501.
8Asano T,Mori T,Shimoda T,et al.Arundic acid ameliorates delayed ischemic brain damage by preventing astrocytic overproduction of S100B[J].Curr Drug Targets CNS Neurol Disord,2005,4(2):127-142.
5McAdory BS,van Eldik LJ,Norden JJ. SIOOB, an euortorphic protein that modulates neuronal protein phosphorylation, is upregulated during lesion-induced collateral sporuting and reactive synaptogenesis[ J]. Brain Res, 1998,813 ( 1 ) :211-217.
6Fassbender K, Schmidt R, Schreiner A, et al. Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic storke[ J]. J Neurol Sci, 1997,148 (1) :101-105.
7Buttner T, Weyers S ,-Postert T,et al . S -100 portein: serum marker of focal braind amagea fteris chemict erritorial MCA infarction [ J ]. Stroke, 1997,28 (10) : 1961-1965.
8Missler U, Wiesmann M, Friedrich C, et al. S-100 protein and neuron-spe- cific enolase concentrations in blood as indicators of infarction volume andporgnosis in acute ischemic storke[ J]. Stroke, 1997,28 ( 10 ) : 1956- 1960.
9Abraha HD, Butterworth RJ, Bath PM, et al. Serum S-100 protein, relationship to clinical outcome in acute stroke[J]. Clin Biochem,1997,34( Pt 5) :546-550.
10Blomquist S, Johnsson P, Luhrs C, et al. The appearance of S-100 protein in serum during and immediately after cardiopulmonary bypasss urgery: a possible marker for cerebral injury [ J ]. Cordiothorac Vasc Anesth, 1997, 11 (6) :699-703.
1Li Q, Chen N, Yang J, et al. Antiviral treatment for prevent- ing postherpetic neuralgia [J~. Cochrane Database Syst Rev, 2009, 15(2):6866.
2Weaver BA.The burden of herpes zoster and postherpetic neuralgia in the United States [J]. J Am Osteopath Assoc, 2007, 107(3): 2-7.
3Jacobson S, Marcus EM. The Cranial Nerves Neuroanato- my for the Neuroscientist I M ]. Springer US, 2011 : 115-134.
4Gilden D, Cohrs R J, Mahalingam R, et al. Neurological disease produced by varicella zoster virus reactivation without rash Varicella-zoster Virus EM~. Springer Berlin Heidelberg, 2010: 243-253.
5Gilden D. Efficacy of live zoster vaccine in preventing zos- ter and postherpetic neuralgia E J ]. Journal of internal medi- cine, 2011, 269(5): 496-506.
6Habib AA, Gilden D, Schmid DS, et al. Varicella zoster vi- rus meningitis with hypoglycorrhachia in the absence of rash and in an immunocompetent woman [J]. J Neurovi- rol, 2009, 15:206-208.
7Gunson RN, Aitken C, Gilden D. A woman with acute headache and sacral dermatomal numbness EJ]. J Clin Vi- rol, 2011, 50:191-193.
8Renner N A, Redmann R K, Moroney-Rasmussen T, et al. S10013 as a novel and accessible indicator for the presence of monocyte-driven encephalitis in AIDS ~ J ]. Neuropathol-ogy and applied neurobiology, 2012, 38 (2): 162-174.
9Shahim P, Blennow K, Zetterberg H. Tau, S-100 Calci- um-Binding Protein B, and Neuron-Specific Enolase as Biomarkers of Concussion-Reply I J]. JAMA Neurology, 2014, 71 (7): 926-927.
10Ben-Amor S, Lammouchi T, Benslamia L, et al. Post vari- cella zoster virus myelitis in immunocompetent patients [J]. Neuroscienees (Riyadh), 2011, 16(2): 156-158.
